Genomic structural variants (SVs) are abundant in humans, differing from other forms of
variation in extent, origin and functional impact. Despite progress in SV characterization, the …

Structural variants are implicated in numerous diseases and make up the majority of varying
nucleotides among human genomes. Here we describe an integrated set of eight structural …

Single‐atom catalysts (SACs), as homogeneous catalysts, have been widely explored for
chemical catalysis. However, few studies focus on the applications of SACs in enzymatic …

The two-dimensional crystalline structures in graphene challenge the applicability of existing
theories that have been used for characterizing its three-dimensional counterparts. It is …

As a new generation of artificial enzymes, nanozymes have the advantages of high catalytic
activity, good stability, low cost, and other unique properties of nanomaterials. Due to their …

Delay tolerant networks (DTNs) may lack continuous network connectivity. Routing in DTNs
is thus challenging since it must handle network partitioning, long delays, and dynamic …

INTRODUCTION The characterization of the full spectrum of genetic variation is critical to
understanding human health and disease. Recent technological advances have made it …

The incomplete identification of structural variants (SVs) from whole-genome sequencing
data limits studies of human genetic diversity and disease association. Here, we apply a suite …

The study of human genomics is becoming a Big Data science, owing to recent biotechnological
advances leading to availability of millions of personal genome sequences, which can …

Sonodynamic therapy (SDT) can overcome the critical issue of depth‐penetration barrier of
photo‐triggered therapeutic modalities. However, the discovery of sonosensitizers with high …